NCT00378066View on ClinicalTrials.gov

Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

October 31, 2008

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Bevacizumab

Bevacizumab, Capecitabine, Oxaliplatin

Trial Locations (6)

Unknown

National Cancer Center, Goyang

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Yonsei University Hospital, Seoul

Bundang Seoul National University Hospital, Sungnam

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT00378066 - Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer | Biotech Hunter | Biotech Hunter